Search results
Namita Thapar Opens Up About Work-Life Balance As Shark: “Taunted As Doing Part Time Job”
Mashable India· 7 days agoEmcure’s Namita Thapar appeared on Karishma Tanna’s latest podcast, ‘Rokda & Dokda’, opening up...
White Rum Vs Dark Rum: What's The Difference?
Daily Meal· 6 days agoDisplay of different rums - Tricky_Shark/Shutterstock Rum is a wonderfully versatile cocktail that's brilliant in anything from a warm-you-from-
Taarak Mehta Ka Ooltah Chashmah, CID, and others: 10 Indian shows that ran for the longest times on...
Pinkvilla· 5 days agoTV shows have been a staple for the Indian masses for ages. People across the nation somehow manage...
Minimising food waste using tech; Powering homes with clean energy
YourStory· 4 days agoThe Ministry of Statistics and Programme Implementation has established a committee to oversee the...
IPO Frenzy: 3 new issues and 11 listings to hit Dalal Street next week
CNBC Awaaz· 5 days agoAdditionally, India's solid macroeconomic environment and promising...growth prospects create an...
Emcure Pharmaceuticals IPO Day 2: From key risks to financials, here are 10 things to know from RHP...
Livemint· 13 hours agoEmcure Pharmaceuticals IPO saw positive investor response with overwhelming demand, offering new...
A Guide to the Rockaways—New York City’s Cool Beach Town
Conde Nast Traveler· 2 days agoMargies—the hotel’s airy, sea-foam blue eatery—serves raw bar platters, handmade pastas, and...
Divine Power Energy shares list with 287% premium on NSE SME platform - The Economic Times
The Economic Times· 3 days agoThe stock listed at Rs 155 as against an offer price of Rs 77. The IPO, which was completely a fresh...
Emcure Pharmaceuticals IPO booked nearly 5x so far on Day 2. Check GMP and other details
The Economic Times· 15 hours agoThe initial public offer (IPO) of Emcure Pharmaceuticals was booked nearly five times so far on...
Emcure Pharmaceuticals IPO: Check subscription on Day 1, GMP and other details - The Economic Times
The Economic Times· 2 days agoThe initial public offer (IPO) of Emcure Pharmaceuticals, which opened earlier today, was booked 66%...